Sign Up to like & get
recommendations!
0
Published in 2020 at "Pharmaceutical Sciences"
DOI: 10.34172/ps.2020.62
Abstract: Background: Repaglinide (REP) is an antihyperglycemic drug having low bioavailability due to its extensive first-pass metabolism. The present study aimed to develop and pharmacokinetic investigte the thiolated chitosan (TC) based buccal tablets of REP for…
read more here.
Keywords:
bioavailability;
rep buccal;
buccal tablets;
study ... See more keywords